← Leaderboards
Paul Thadikonda
$1,018,566
Attributed
$1,018,566
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $533.6K · FY2017–18$1M$750K$500K$250K$0
'17
'18
Funding mix
By agency
NIH$1,018,566 · 1
By mechanism
N01$1,018,566 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Biodefense”
- Ryan Cirz · Revagenix, Inc.$17,912,826
- Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr$16,660,001
- Nadine Georges Rouphael · Emory University$14,072,741
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$9,683,666
- Karen Marie Dobos · Colorado State University$8,846,494
- Evan J Anderson · Emory University$7,773,636
Research focus
BiodefenseClinical ResearchClinical TrialsConduct Clinical TrialsContractsEquipment And Supply InventoriesImmune ToleranceInvestigationLabelPlacebosPreparationRegulationResearch PersonnelResearch StudyServices